Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Istanbul - Delayed Quote TRY

Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi (ONCSM.IS)

86.55
-1.75
(-1.98%)
As of 11:42:16 AM GMT+3. Market Open.
Loading Chart for ONCSM.IS
  • Previous Close 88.30
  • Open 88.30
  • Bid 86.25 x --
  • Ask 86.55 x --
  • Day's Range 84.55 - 88.55
  • 52 Week Range 84.55 - 215.00
  • Volume 108,826
  • Avg. Volume 396,102
  • Market Cap (intraday) 2.064B
  • Beta (5Y Monthly) 0.88
  • PE Ratio (TTM) --
  • EPS (TTM) -2.50
  • Earnings Date --
  • Forward Dividend & Yield 0.41 (0.44%)
  • Ex-Dividend Date Nov 8, 2023
  • 1y Target Est --

Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi provides consumables, medical devices, diagnostic products, and protective equipment. The company offers OncoCare Monolitik, an automated chemotherapy drug preparation device; OncoCare Plus, a chemotherapy drug guide; OncoWaste and M-Waste, a hazardous waste sealing system; OncoCare Set, a chemotherapy preparation and administration consumables; and Oncocare Infusion Pump. It also provides Oncosem components, such as pinch clamps, roller clamps, 3/4 way connectors, vial adapters, drip chambers, hydrophobic caps, male and rotating luer locks, spikes, taxol filters, check valves, and covers. The company was incorporated in 2008 and is headquartered in Ankara, Turkey.

www.oncosem.com

292

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ONCSM.IS

View More

Performance Overview: ONCSM.IS

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is BIST 100 (XU100.IS) .

YTD Return

ONCSM.IS
18.43%
BIST 100 (XU100.IS)
6.71%

1-Year Return

ONCSM.IS
50.91%
BIST 100 (XU100.IS)
8.71%

3-Year Return

ONCSM.IS
349.61%
BIST 100 (XU100.IS)
277.31%

5-Year Return

ONCSM.IS
349.61%
BIST 100 (XU100.IS)
90.93%

Compare To: ONCSM.IS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ONCSM.IS

View More

Valuation Measures

Annual
As of 4/29/2025
  • Market Cap

    2.11B

  • Enterprise Value

    2.11B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.62

  • Price/Book (mrq)

    7.68

  • Enterprise Value/Revenue

    5.63

  • Enterprise Value/EBITDA

    56.76

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -15.80%

  • Return on Assets (ttm)

    0.77%

  • Return on Equity (ttm)

    -19.44%

  • Revenue (ttm)

    374.49M

  • Net Income Avi to Common (ttm)

    -59.17M

  • Diluted EPS (ttm)

    -2.50

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    44.66M

  • Total Debt/Equity (mrq)

    17.00%

  • Levered Free Cash Flow (ttm)

    49.13M

Research Analysis: ONCSM.IS

View More

Company Insights: ONCSM.IS

Research Reports: ONCSM.IS

View More

People Also Watch